Productivity drive could affect up to 4,000 Novartis jobs in 2014
Novartis has confirmed that pharma jobs will be reallocated in 2014 in a continuation of the productivity drive that saved the firm $2.8bn (EUR2bn) last year.
Archives for February 3, 2014
Lupin buys Dutch delivery tech firm for injectables entry
Lupin Ltd has bought Dutch delivery technology company Nanomi BV in a deal that moves the Indian generics firm into the complex injectables space.
Avoca prepares for survey, summit on CRO, sponsor partnerships
A consortium of sponsors and CROs are beginning to participate in a survey that will not only assess their perceptions of quality but how those perceptions have stacked up over the years.
“Shadows” help prevent unpleasant surprises for CMOs says Melinta
Private antibiotics developer Melinta has established a team of “shadow” scientists who streamline research before outsourcing drug manufacture.
Chicken pox vaccine shortage likely after problems at GSK plant
Shipments of chicken pox vaccines from a troubled Belgian facility should recommence in early Q2 2014, says GSK, though the root cause of the manufacturing issues are still unknown.
CTI Trial, Clinical Consulting acquire Community Research
CROs CTI Trial and Clinical Consulting recently acquired Community Research, David Blume, managing director of Edgemont Capital, told us.
Parexel tops analysts’ revenue, EPS expectations for Q2
Parexel narrowly beat investment analysts’ earnings per share and revenue expectations as consolidated service revenue hit $487.1m.
Early Phase revival but over-capacity dictates prices, says analyst
Demand for early phase services have increased but the industry is still “far away from the boom times of the early to mid 2000s,” according to an ISI analyst.